---
title: "花旗銀行維持對安進（AMGN）的持有評級"
description: "根據 TipRanks 的數據，Meacham 是一位四星分析師，平均回報率為 4.2%，成功率為 55.14%。Meacham 覆蓋醫療保健行業，專注於如禮來公司（Eli Lilly & Co）、安進（Amgen）和 Vertex 製藥等股票。除了花旗集團，安進在 10 月 10 日的報告中也獲得了 Raymond James 的 Christopher Raymond 的持有評級。然而，在 1"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/260882086.md"
published_at: "2025-10-13T10:55:50.000Z"
---

# 花旗銀行維持對安進（AMGN）的持有評級

> 根據 TipRanks 的數據，Meacham 是一位四星分析師，平均回報率為 4.2%，成功率為 55.14%。Meacham 覆蓋醫療保健行業，專注於如禮來公司（Eli Lilly & Co）、安進（Amgen）和 Vertex 製藥等股票。除了花旗集團，安進在 10 月 10 日的報告中也獲得了 Raymond James 的 Christopher Raymond 的持有評級。然而，在 10 月 8 日，RBC Capital 對安進（NASDAQ: AMGN）維持了買入評級

根據 TipRanks 的數據，Meacham 是一位 4 星分析師，平均回報率為 4.2%，成功率為 55.14%。Meacham 覆蓋醫療保健行業，關注的股票包括禮來公司、安進和 Vertex 製藥。

除了花旗，安進在 10 月 10 日的報告中也獲得了 Raymond James 的 Christopher Raymond 的持有評級。然而，在 10 月 8 日，RBC Capital 維持了對安進（NASDAQ: AMGN）的買入評級。

### Related Stocks

- [AMGN.US - 安進](https://longbridge.com/zh-HK/quote/AMGN.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Amgen Conference: UPLIZNA Phase III Plans, Daxdilimab Lupus Data, and TEZSPIRE Expansion Update | Amgen executives discussed upcoming clinical milestones and data updates in their inflammation and immunology portfolio. | [Link](https://longbridge.com/zh-HK/news/275831709.md) |
| Amgen receives EC approval for Uplizna in generalised myasthenia gravis | Amgen has received European Commission approval for Uplizna (inebilizumab) as an add-on treatment for adults with genera | [Link](https://longbridge.com/zh-HK/news/275884466.md) |
| REG - Morgan Stanley&CoLLC Avadel Pharma plc - Rule 38.5_A - Avadel Pharmaceuticals plc | Morgan Stanley & Co. LLC disclosed dealings related to Avadel Pharmaceuticals plc under Rule 38.5(a) of the Irish Takeov | [Link](https://longbridge.com/zh-HK/news/275721511.md) |
| Where Were The Job Opportunities In 2025? Where Will They Be In 2026? | In 2025, job growth was minimal, with only Education and Health Care (+697,000 jobs) and Leisure and Hospitality (+119,0 | [Link](https://longbridge.com/zh-HK/news/275986113.md) |
| REG - Rubric Capital Mgmt Avadel Pharma plc - Form 8.3 - Avadel Pharmaceuticals plc | Rubric Capital Management LP disclosed its position in Avadel Pharmaceuticals plc under Rule 8.3 of the Irish Takeover P | [Link](https://longbridge.com/zh-HK/news/275770954.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。
